Fed. Circ. Revives Tamiflu Case, Expands Double-Patenting
The Federal Circuit ruled Tuesday that a patent can be rendered invalid for double-patenting based on a patent that expires before it, expanding the double-patenting doctrine and giving Natco Pharma Ltd....To view the full article, register now.
Already a subscriber? Click here to view full article